Aidoc, a leading healthcare AI provider, introduced seven new AI solutions to the European healthcare market. These additions mark a significant expansion of Aidoc’s award-winning aiOS platform , which alerts radiologists and care teams to suspected urgent pathology in medical images, ensuring rapid patient care.
The new algorithms, all of which have now received CE marking for medical devices under the MDR, include four solutions for the reporting and screening of urgent conditions: vascular occlusion, aortic dissection, vertebral compression fractures and malpositioned endotracheal tube. In addition, three new quantification solutions provide standardized quantitative assessments of cardiovascular and neurological conditions: midline shift, coronary artery calcification and abdominal aorta measurement.
With this latest release, Aidoc’s aiOS™ platform now offers 26 AI solutions approved for the European market, including 17 algorithms developed in-house and others developed through strategic partnerships. This comprehensive suite of CE-marked clinical AI solutions is deployed through the Aidoc aiOS™ platform, providing a seamless and unified user experience. Together with Aidoc’s care coordination and patient monitoring capabilities, this approach solidifies Aidoc as the leading provider of end-to-end AI solutions for healthcare.
“Healthcare systems in Europe are facing serious challenges related to increasing patient backlogs and staff shortages. To address these challenges, we are taking clinical AI to the next level by increasing the speed and scope of development and implementation of new AI modules,” said Alexander Boehmcker, Vice President, Europe , Aidoc. “Aidoc has already established itself as the leading clinical AI platform. With the launch of these new solutions, we have increased our ability to flag more conditions and provide important metrics with our new quantification solutions. Combined with our platform’s ability to rapidly activate care teams and ensure rigorous patient monitoring, we are able to achieve better outcomes for patients and providers. I am particularly proud that all of our Aidoc AI modules are now CE marked in accordance with the new MDR.”
Also Read: RhythmX AI Welcomes Nathan Gnanasambandam as Vice President of AI
Aidoc’s AI platform, which is widely deployed across Europe , is already backed by substantial evidence demonstrating its effectiveness in addressing Europe ’s healthcare challenges. For example, a recent study using Aidoc AI at the Netherlands Cancer Institute reported a 98% reduction in patient waiting times for notification of incidental pulmonary embolism, a common comorbidity in oncology patients.
In addition, providers themselves are feeling the benefits of Aidoc AI, as evidenced by survey results presented by leading teleradiology provider Reif & Möller at the European Congress of Radiology in Vienna. These results revealed that 97% of teleradiologists no longer want to work without AI, and 85% of them report increased job satisfaction directly attributable to its implementation.
Aidoc’s introduction of these new AI solutions underscores its commitment to supporting Europe’s overstretched healthcare systems. Already processing millions of patient scans each month, this latest release underscores Aidoc’s unwavering commitment to equipping providers with cutting-edge tools to deliver better patient outcomes, driving positive change across the healthcare sector.
Source: PRNewswire
